Shorter stature linked to higher risk of heart disease, studies show

Shorter adults face a higher risk of coronary heart disease and stroke than taller peers, according to research and experts who point to a mix of biological and social factors that may help explain the association.

A large-scale analysis published in The New England Journal of Medicine in 2015 found that each additional 2.5 inches (6.5 centimetres) in height was associated with a 13 percent lower risk of coronary heart disease. That study also reported that a person about 5 feet tall was roughly 32 percent more likely to develop heart disease than someone about 5 feet 6 inches tall.

Medical commentators have emphasised that the relationship between height and cardiovascular risk is complex and not a cause for complacency among taller people. "A large-scale study published in The New England Journal of Medicine found that each additional 2.5in (6.5cm) in height was associated with a 13 per cent lower risk of coronary heart disease," said Dr. Peter Fotinos, medical director at Male Excel. He added that scientists "believe this may be partly due to larger arteries and better lung capacity in taller people."

Public health groups have warned that the burden of heart conditions is rising irrespective of height. The British Heart Foundation says diagnoses of heart failure have increased by 21 percent since 2020, the largest rise on record, underscoring the continuing public-health challenge posed by cardiovascular disease.

Researchers caution that studies linking height and heart disease are observational and cannot prove that height itself directly causes heart problems. Investigators point to a number of plausible explanations for the association that involve both biology and life-course conditions. Taller individuals tend to have larger-calibre arteries and greater lung capacity, factors that could confer cardiovascular advantages. Early-life nutrition, illnesses in childhood, genetic influences and socioeconomic conditions that affect growth and lifelong health behaviours may also contribute to the observed patterns.

Analyses of height and heart disease adjust for many conventional risk factors, but residual confounding remains a possibility. Socioeconomic status, access to health care, childhood environment and genetic variation can all influence both adult height and cardiovascular outcomes, and disentangling those influences is an ongoing area of research.

Clinicians and public-health experts say the practical implications are that height may be one of many markers that help identify people at elevated cardiovascular risk, but it does not change standard prevention advice. Height is not modifiable in adults; well-established strategies to reduce heart-disease risk include controlling blood pressure and cholesterol, avoiding tobacco, maintaining a healthy weight, staying physically active and following medical guidance on medication when appropriate.

Although shorter stature is associated with increased risk at the population level, experts emphasise that most cardiovascular risk is driven by modifiable factors. "Being tall isn't a reason to feel smug about your heart health," Dr. Fotinos said, adding that clinicians should continue to focus on established risk factors in individual patients.

Ongoing research seeks to clarify how height interacts with conventional and emerging risk markers and whether incorporating height into risk calculators would meaningfully improve prevention or early detection. For now, public-health authorities continue to prioritise interventions that target the major drivers of heart disease across the population.

The 2015 NEJM analysis and subsequent studies have prompted renewed attention to how life-course influences shape cardiovascular outcomes. The message from researchers and clinicians is consistent: height may help explain part of the variation in heart-disease risk between people, but addressing modifiable risk factors remains the primary route to preventing disease and reducing mortality.